4'-Methoxy-α-Pyrrolidinopentiophenone: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
m 1 revision imported |
(No difference)
| |
Latest revision as of 20:28, 12 March 2025
4'-Methoxy-α-Pyrrolidinopentiophenone (MOPPP) is a designer drug that belongs to the cathinone class. It is a synthetic stimulant of the amphetamine class. MOPPP is a higher homologue of 4'-Methyl-α-pyrrolidinopentiophenone (MPPP), and is often used in the research of central nervous system disorders.
Chemistry[edit]
4'-Methoxy-α-Pyrrolidinopentiophenone is a synthetic cathinone. Cathinones are a sub-category of amphetamines, which are organic compounds with a phenethylamine core. The chemical structure of MOPPP includes a phenyl ring bound to an amino (NH2) group through an ethyl chain with a ketone group at the beta carbon. It also has an additional methoxy group at the 4' position of the phenyl ring.
Pharmacology[edit]
The pharmacological properties of 4'-Methoxy-α-Pyrrolidinopentiophenone are not well-studied. However, it is known that synthetic cathinones are generally monoamine releasers. They are believed to enhance the release of monoamines like dopamine, norepinephrine, and serotonin in the brain, leading to stimulant effects.
Legality[edit]
The legality of 4'-Methoxy-α-Pyrrolidinopentiophenone varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and addiction. In the United States, it is a Schedule I controlled substance under the Controlled Substances Act.
See Also[edit]
